Cytokinetics Inc (STU:KK3A) Stock News, Headlines & Updates
Cytokinetics Inc Stock News from GuruFocus
- 1
- 2
Jul 10, 2025
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
Marketwired • 7:00am
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 | CYTK Stock News
GuruFocus News • 6:48am
Jul 08, 2025
Insider Sell: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 5:00pm
Jun 18, 2025
Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 7:01pm
Jun 17, 2025
Cytokinetics Inc (CYTK) Announces Stock Options and RSUs for New Employees | CYTK stock news
GuruFocus News • 4:11pm
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CYTK Stock News
GuruFocus News • 3:19pm
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 3:00pm
Jun 10, 2025
Cytokinetics Inc (CYTK) Launches 2025 Corporate Giving Program | CYTK stock news
GuruFocus News • 8:03am
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
Marketwired • 7:00am
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program | CYTK Stock News
GuruFocus News • 6:57am
Jun 09, 2025
JP Morgan Lowers Price Target for Cytokinetics (CYTK) to $53 | CYTK Stock News
GuruFocus News • 11:31am
Cytokinetics (CYTK) Target Price Cut by JPMorgan Analyst | CYTK Stock News
GuruFocus News • 6:15am
Jun 05, 2025
Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 5:01pm
Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 5:01pm
Jun 03, 2025
Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 5:01pm
May 29, 2025
Cytokinetics Inc (CYTK) to Participate in Jefferies Global Healthcare Conference | CYTK stock news
GuruFocus News • 4:01pm
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
Marketwired • 4:00pm
Cytokinetics (CYTK) Stock Update: Mizuho Lowers Price Target | CYTK Stock News
GuruFocus News • 12:00pm
Cytokinetics (CYTK) Gets Price Target Reduction from Mizuho Analyst | CYTK Stock News
GuruFocus News • 7:50am
May 20, 2025
Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 5:00pm
May 18, 2025
Cytokinetics (CYTK) Showcases Promising Aficamten Data for HCM Treatment | CYTK Stock News
GuruFocus News • 10:15am
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress | CYTK Stock News
GuruFocus News • 7:15am
Cytokinetics Inc (CYTK) Unveils New Data on Aficamten's Efficacy in HCM Patients | CYTK stock news
GuruFocus News • 7:00am
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Marketwired • 7:00am
May 16, 2025
Cytokinetics Inc (CYTK) Announces Stock Options and RSUs as Inducements for New Employees | CYTK stock news
GuruFocus News • 4:01pm
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CYTK Stock News
GuruFocus News • 3:18pm
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 3:00pm
Insider Sell: Muna Bhanji Sells 1,454 Shares of Cytokinetics Inc (CYTK)
GuruFocus News • 9:01pm
May 15, 2025
Cytokinetics Inc (CYTK) Announces Second Annual Muscle Biology Research Symposium | CYTK stock news
GuruFocus News • 7:14am
Cytokinetics (CYTK) to Host Muscle Biology Symposium in 2025 | CYTK Stock News
GuruFocus News • 7:01am
Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology
Marketwired • 7:00am
Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology | CYTK Stock News
GuruFocus News • 6:50am
May 14, 2025
Needham Reiterates Buy Rating on Cytokinetics (CYTK) with $72 Price Target | CYTK Stock News
GuruFocus News • 6:31am
May 13, 2025
Cytokinetics (CYTK) Rallies as Phase 3 Trial Succeeds for Lead Drug
GuruFocus News • 8:56am
Cytokinetics Inc (CYTK) Announces Positive Phase 3 Trial Results for Aficamten | CYTK stock news
GuruFocus News • 8:20am
Cytokinetics (CYTK) Reports Positive Results from Phase 3 Clinical Trial | CYTK Stock News
GuruFocus News • 7:01am
Cytokinetics Announces Positive Topline Results From MAPLE-HCM
Marketwired • 7:00am
Cytokinetics Announces Positive Topline Results From MAPLE-HCM | CYTK Stock News
GuruFocus News • 6:48am
May 08, 2025
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news